These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Clozapine for resistant schizophrenia and characteristics of those responding].
    Author: Talmon Y, Guy N, Wittenberg N.
    Journal: Harefuah; 1995 Dec 01; 129(11):451-4, 536. PubMed ID: 8846949.
    Abstract:
    Clozapine (Leponex) is an atypical antipsychotic drug which is effective in the treatment of resistant schizophrenia. The most severe side-effect is agranulocytosis, which occurs in 12%. 50 patients with resistant schizophrenia were screened retrospectively in order to characterize features which might help predict good response to the drug. The drug was more effective in young patients with recent onset of illness and short total duration of hospitalization.
    [Abstract] [Full Text] [Related] [New Search]